BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30143500)

  • 21. Association of P2X7 A1513C (rs3751143) gene polymorphism with risk of tuberculosis: evidence from a meta-analysis.
    Areeshi MY; Mandal RK; Panda AK; Haque S
    Genet Test Mol Biomarkers; 2013 Sep; 17(9):662-8. PubMed ID: 23947898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FAS -1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls.
    Qiu LX; Shi J; Yuan H; Jiang X; Xue K; Pan HF; Li J; Zheng MH
    Hum Genet; 2009 May; 125(4):431-5. PubMed ID: 19225810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk.
    Ke P; Wu ZD; Wen HS; Ying MX; Long HC; Qing LG
    Asian Pac J Cancer Prev; 2013; 14(4):2269-72. PubMed ID: 23725125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between matrix metalloproteinases polymorphisms and ovarian cancer risk: A meta-analysis and systematic review.
    Zhu XM; Sun WF
    PLoS One; 2017; 12(9):e0185456. PubMed ID: 28957437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.
    Xia W; Xu Y; Mao Q; Dong G; Shi R; Wang J; Zheng Y; Xu L; Jiang F
    Med Oncol; 2015 Feb; 32(2):442. PubMed ID: 25603950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
    Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
    J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
    Li YL; Tian Z; Zhao L; Zhang CL
    Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between CTLA-4 (+49 A/G) polymorphism and susceptibility to ankylosing spondylitis: a meta-analysis.
    Wu J; Zhang L; Zhou Y
    Int J Rheum Dis; 2016 Dec; 19(12):1237-1243. PubMed ID: 26176417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of
    Liang Y; Han W; Yan H; Mao Q
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S463-S467. PubMed ID: 29970707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
    Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
    Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
    Li T; Huang H; Liao D; Ling H; Su B; Cai M
    Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies.
    Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y
    DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HOGG1 Ser326Cys polymorphism and susceptibility to head and neck cancer: a meta-analysis.
    Liu J; Cao XL; Zhang Z; Lei DP; Jin T; Yu XM; Pan XL
    Asian Pac J Cancer Prev; 2011; 12(10):2491-4. PubMed ID: 22320944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of angiotensin ІІ type 1 receptor gene A1166C polymorphism with cancer risk: An updated meta-analysis.
    Hu X; Chen J
    J Renin Angiotensin Aldosterone Syst; 2019; 20(1):1470320319827207. PubMed ID: 30798689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of microRNA-146a rs2910164 G>C polymorphism association with autoimmune diseases susceptibility, an update based on 24 studies.
    Li C; Fu W; Zhang Y; Zhou L; Mao Z; Lv W; Li J; Zhou Y
    PLoS One; 2015; 10(4):e0121918. PubMed ID: 25830862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.
    Shi S; Qin L; Tian M; Xie M; Li X; Qi C; Yi X
    Tumour Biol; 2014 Jun; 35(6):5797-804. PubMed ID: 24599673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis.
    Yang D; Liu C; Shi J; Wang N; Du X; Yin Q; Wang Y
    Gene; 2014 Jan; 534(1):17-23. PubMed ID: 24176953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between MTHFR gene 1298A>C polymorphism and breast cancer susceptibility: a meta-analysis based on 38 case-control studies with 40,985 subjects.
    Zhang J; Zhang L; Li G
    World J Surg Oncol; 2016 Aug; 14(1):230. PubMed ID: 27568010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TLR2 Arg753Gln Gene Polymorphism Associated with Tuberculosis Susceptibility: An Updated Meta-Analysis.
    Hu L; Tao H; Tao X; Tang X; Xu C
    Biomed Res Int; 2019; 2019():2628101. PubMed ID: 30733958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Association of ERCC6 rs2228526 Polymorphism with the Risk of Cancer: Evidence from a Meta-Analysis.
    Lin X; Wu Y; Li Q; Yu H; Li X; Li X; Zheng J
    Biomed Res Int; 2022; 2022():2662666. PubMed ID: 35463969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.